AU1005270A - 19 homo steroids - Google Patents

19 homo steroids

Info

Publication number
AU1005270A
AU1005270A AU10052/70A AU1005270A AU1005270A AU 1005270 A AU1005270 A AU 1005270A AU 10052/70 A AU10052/70 A AU 10052/70A AU 1005270 A AU1005270 A AU 1005270A AU 1005270 A AU1005270 A AU 1005270A
Authority
AU
Australia
Prior art keywords
homo steroids
steroids
homo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU10052/70A
Other languages
English (en)
Inventor
MARCEL MULLER and PETER MULLER ANDOR FURST
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU1005270A publication Critical patent/AU1005270A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
AU10052/70A 1969-01-16 1970-01-06 19 homo steroids Expired AU1005270A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH63769 1969-01-16
CHCH637/69 1969-01-16

Publications (1)

Publication Number Publication Date
AU1005270A true AU1005270A (en) 1971-07-08

Family

ID=4191643

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10052/70A Expired AU1005270A (en) 1969-01-16 1970-01-06 19 homo steroids

Country Status (6)

Country Link
US (1) US3642839A (fr)
AU (1) AU1005270A (fr)
BE (1) BE744456A (fr)
DE (1) DE2001262A1 (fr)
FR (1) FR2034471A1 (fr)
NL (1) NL7000357A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone

Also Published As

Publication number Publication date
FR2034471A1 (fr) 1970-12-11
BE744456A (fr) 1970-07-15
NL7000357A (fr) 1970-07-20
DE2001262A1 (de) 1970-07-30
US3642839A (en) 1972-02-15

Similar Documents

Publication Publication Date Title
CA965975A (en) 1,2-benzoisothiazoles
CA954855A (en) N(6)-alkyl-adenosine derivatives
AU1005270A (en) 19 homo steroids
CA952899A (en) Steroids
CA804030A (en) Substituted 1 h-tetrazoles
CA807146A (en) 4,17-dioxygenated steroids
CA806656A (en) 6.beta.:9-OXIDO STEROIDS
CA825152A (en) SUBSTITUTED 17.alpha.-BUTADIYNYL STEROIDS
AU413111B2 (en) 17-hydroxygona-5(10)-en-3-ones
AU295123B2 (en) 17 hydroxygona 4 en 3-ones
AU434727B2 (en) 1 carbamoyl-3 phenylpyrrolidines
AU440061B2 (en) 1 acylhydroquinolines
AU443786B2 (en) 13 polycarbonalkyl 18-norpregnenes
AU446520B2 (en) 4 hydrazonomethylthiazole antitrypanocides
AU439543B2 (en) 1 substituted 3 phenylpyrrolidines
CA820881A (en) Pro-oestrogenic steroids
CA818495A (en) 19-hydroxy-19-alkyl steroids
CA824142A (en) Steroids
CA822103A (en) Steroids
CA807645A (en) Steroids
CA809653A (en) 3-hydroxy-19-alkyl steroids
CA816073A (en) Steroids
CA818492A (en) Steroids
CA812238A (en) 4(pyrazolyl-(1))-naphthalimides
CA808698A (en) 2,2-dichloro-1,1,3,3-tetrafluoropropane